<DOC>
	<DOCNO>NCT00680056</DOCNO>
	<brief_summary>The primary objective comparatively evaluate isolated effect long-acting beta2-adrenergic ( formoterol fumarate 12µg b.i.d . via Aeroliser ) combine long-acting anti-cholinergic ( tiotropium bromide 18µg o.d via Handihaler ) breathlessness , dynamic hyperinflation exercise tolerance patient advance , stable , chronic obstructive pulmonary disease . The study hypothesis combine long acting bronchodilator different action mechanism would promote synergistic effect clinical outcome .</brief_summary>
	<brief_title>Add-on Effects Tiotropium Over Formoterol Exercise Tolerance Chronic Obstructive Pulmonary Disease Patients</brief_title>
	<detailed_description>This single center , randomize , double-blind study consist two 2-week treatment period separate 5-7 day washout phase without long-acting bronchodilator . Eligible patient complete one week screen phase randomize one two treatment sequence : 1 ) Formoterol -- &gt; Formoterol + Tiotropium 2 ) Formoterol + Tiotropium -- &gt; Formoterol . During treatment period , patient allow use short-acting beta2-adrenergic+short-acting anticholinergic rescue medication ( salbutamol+ipratropium via MDI )</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Bronchitis , Chronic</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>COPD patient age ≥ 40 year stable moderatetosevere airflow obstruction ( FEV1 &lt; 70 % FEV1/FVC ≤ 70 % predict normal value ) postbronchodilator present long history smoking ( &gt; 20 packyears ) chronic breathlessness ( Baseline Dyspnoea Index total score &lt; 9 ) significant cardiovascular disease , hospitalization COPD exacerbation presence respiratory tract infection within 1 month screen current childhood asthma history allergic rhinitis atopic disease inability interrupt usual bronchodilator medication use oral steroid within month screen need longterm oxygen therapy , arterial oxygen saturation &lt; 85 % rest anemia , hypo hyperthyroidism , hyperadrenergic state uncontrolled insulin dependent diabetes mellitus , malignancy , disease condition limit exercise performance COPD change inhale corticosteroid theophylline use within 1 month prior screen</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Pulmonary Disease , Chronic Obstructive</keyword>
	<keyword>Tiotropium</keyword>
	<keyword>Formoterol</keyword>
	<keyword>Bronchodilator Agents</keyword>
	<keyword>Exercise Tolerance</keyword>
	<keyword>Randomized Controlled Trial [ Publication Type ]</keyword>
	<keyword>COPD</keyword>
</DOC>